Beijing Xuze Pharmaceutical Technology Co., Ltd. (北京旭泽医药科技有限公司)

概览

关联

4

项与北京旭泽医药科技有限公司相关的临床试验

CTR20242780 / Recruiting临床4期

评价卡波姆产道凝胶上市后有效性和安全性的单臂、多中心临床研究。

评价卡波姆产道凝胶在初产妇自然分挽时的有效性和安全性

开始日期2024-08-21

申办/合作机构

成都英诺新科技有限公司

[+1]

NCT03488186 / Completed临床1期IIT

A Randomized, Open Label, Parallel, Single and Multiple Doses Designed Clinical Study to Evaluate Comparative Pharmacokinetics (PK)-Pharmacodynamics (PD) After Oral Administration of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers

The objective of this study was to compare the relative PK-PD of Lansoprazole Capsules and Lansoprazole DR Capsules in healthy Chinese volunteers.

开始日期2018-07-19

申办/合作机构

The First Affiliated Hospital, Zhejiang University School of Medicine

[+1]

NCT03488173 / Completed临床1期IIT

Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer

The objective of this study was to compare pharmacokinetic of Lansoprazole Capsules 30 mg with Lansoprazole Capsules of Takeda 30 mg in healthy adult human subjects.

开始日期2018-04-23

申办/合作机构

The First Affiliated Hospital, Zhejiang University School of Medicine

[+1]

100 项与北京旭泽医药科技有限公司相关的临床结果

登录后查看更多信息

0 项与北京旭泽医药科技有限公司相关的专利（医药）

登录后查看更多信息

100 项与北京旭泽医药科技有限公司相关的药物交易

登录后查看更多信息

100 项与北京旭泽医药科技有限公司相关的转化医学

登录后查看更多信息